Moderna shares tumble as reported results for its cancer vaccine with Merck circulated ahead of a planned conference ...

Moderna released full data on its closely watched cancer vaccine developed with Merck.

Mass General Brigham researchers from the Gene Lay Institute of Immunology and Inflammation, along with researchers at ...

Nonclinical studies demonstrated reductions in two key measures of neuropathic painOngoing Phase 2 CAReS trial includes pain endpoints to ...

Eli Lilly's olomorasib showed 62% tumor response in KRAS G12C-mutant lung cancer at ESMO 2026, but data comes from ...

Immunocore will present Phase 1 data for brenetafusp plus KIMMTRAK® (tebentafusp-tebn) in metastatic uveal melanoma, during a late-breaking oral ...

A simple blood test to detect cancer before symptoms even appear: that’s the promise of liquid biopsy, a rapidly developing ...

A supervised neural network called SuRe outperforms established methods at inferring mutational signature exposures from ...

How cells are arranged within tissue can reveal as much about disease as the cells themselves. When doctors examine a cancer ...

After sitting through the full presentation on the Phase 3 INTerpath-001 trial at the ESMO Congress over the weekend, ...

BioNTech opened a Melbourne mRNA facility on 21 October, while mixed cancer trial data and a planned Tübingen closure frame ...

At one of the year’s premiere meetings for cancer research, melanoma vaccine data hailed by scientists sparked a share ...